Enhanced in Vivo IgE Production and T Cell Polarization Toward the Type 2 Phenotype in Association with Indoor Exposure to VOC: Results of the LARS Study
Overview
Public Health
Authors
Affiliations
The association between indoor exposure to volatile organic compounds (VOC), prevalence of allergic sensitization and cytokine secretion profile of peripheral T cells was studied in 3 year old children of the LARS study (Leipzig Allergy Risk Children Study) to investigate the role of VOC exposure as a risk factor for the development of atopic disease. Indoor VOC exposure was measured over a period of 4 weeks in infants' bedrooms using a passive sampling system. Specific IgE antibodies to food, indoor and outdoor allergens were measured by the Pharmacia CAP system and correlated to VOC exposure (n = 120). In addition, cytokine producing peripheral T cells (interleukin(IL)-4, interferon(IFN)-gamma) were measured in a subgroup of 28 children by means of intracellular cytokine staining. For the first time we were able to show that exposure to alkanes (C6, C9, C10) and aromatic compounds (toluene, o-xylene, m + p-xylene, 2-, 3- and 4-ethyl-toluene, chlorobenzene) may contribute to the risk of allergic sensitization to the food allergens milk and egg white (Odds ratios between 5.7 and 11.2). Moreover, significantly reduced numbers of CD3+/CD8+ peripheral T cells were found in children exposed to alkanes (C9-C13), naphthalene and chlorobenzene. Exposure to benzene, ethylbenzene and chlorobenzene was associated with higher percentages of IL-4 producing CD3+ T cells. Both an increase in IL-4 producing type 2 T cells and a reduction of IFN-gamma producing type 1 T cells may contribute to a type 2 skewed memory in response to allergens. Therefore, we suggest exposure to VOCs in association with allergic sensitization to be mediated by a T cell polarization toward the type 2 phenotype.
Exposure to Volatile Organic Compounds May Contribute to Atopic Dermatitis in Adults.
Tang K, Chen Y, Lee M, Chen T, Lai C, Lin C Biomedicines. 2024; 12(7).
PMID: 39061993 PMC: 11274632. DOI: 10.3390/biomedicines12071419.
Atopic Dermatitis: Pathophysiology.
Boothe W, Tarbox J, Tarbox M Adv Exp Med Biol. 2024; 1447:21-35.
PMID: 38724781 DOI: 10.1007/978-3-031-54513-9_3.
Mendy A, Burcham S, Merianos A, Mersha T, Yolton K, Chen A Toxics. 2024; 12(4).
PMID: 38668512 PMC: 11054577. DOI: 10.3390/toxics12040289.
Zhang R, Weschler L, Ye J, Wang Z, Deng Q, Li B Heliyon. 2023; 9(11):e21718.
PMID: 38027650 PMC: 10661510. DOI: 10.1016/j.heliyon.2023.e21718.
Fadadu R, Abuabara K, Balmes J, Hanifin J, Wei M Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767891 PMC: 9916398. DOI: 10.3390/ijerph20032526.